Spark Investment Management LLC Aurinia Pharmaceuticals Inc. Transaction History

Spark Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 12, 2019	SELL	$6.05 - $6.75 $66,550 - $74,250	-11,000 Closed	0 $0
Q1 2019 May 07, 2019	BUY	$6.06 - $7.64 $66,660 - $84,040	11,000 New	11,000 $71,000
Q4 2018 Feb 12, 2019	SELL	$5.08 - $6.83 $91,440 - $122,940	-18,000 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$5.27 - $6.64 $94,859 - $119,520	18,000 New	18,000 $118,000
Q1 2018 May 10, 2018	SELL	$4.85 - $5.99 $163,445 - $201,863	-33,700 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$4.53 - $7.09 $152,661 - $238,933	33,700	33,700 $153,000

208

58.6M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.24B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.